Taiwan FDA registration 53ee1df19eebe7a259d4a4412f18b1e4
Feiyang Sugar Blood Glucose Detection System
TW: 飛暘必析糖血糖檢測系統
Taiwan·Risk Class 2·HMD BIOMEDICAL INC.·Registered Mar 17, 2022 – Jun 20, 2026ExpiredRegistration details
- Analysis ID
- 53ee1df19eebe7a259d4a4412f18b1e4
Company information
- Manufacturer
- HMD BIOMEDICAL INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- HMD BIOMEDICAL INC.
Product details
- Intended Use
- Feiyang Sugar Glucose Analyzer is made by electrochemical biological sensing technology, which can only be used in combination with Feiyang Sugar Glucose Glucose Test Tablet to provide diabetic patients with home detection of blood glucose values of microvascular whole blood. And under the operation of professionals, the blood glucose value of adult microvascular, venous blood and whole blood of newborn infants can be measured.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- 國產;; QMS/QSD
Dates and status
- Registration Date
- Mar 17, 2022
- Expiry Date
- Jun 20, 2026
About this record
Access comprehensive regulatory information for Feiyang Sugar Blood Glucose Detection System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 53ee1df19eebe7a259d4a4412f18b1e4 and manufactured by HMD BIOMEDICAL INC.. The authorized representative in Taiwan is HMD BIOMEDICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices